The promise of a cure

Building the Next Generation Gene Therapies
with Advanced Lentiviral Vectors

At Genespire we develop first-in-class gene therapies with the aim of curing people affected by severe diseases.

Our therapies are based on proprietary advanced lentiviral vector platforms and are designed to provide a one-time treatment, allowing stable and prolonged expression of therapeutic genes.